Presentation- iValue: The Biological Pacemaker 3929
Columbia University is developing a biological pacemaker for human use, offering a cure, rather than the palliation provided by electronic pacemakers, for heart arrhythmia. It uses encapsulated stem cells transfected with the pacemaking gene, which is a path-breaking approach to the treatment of disease. The presenting organization has assembled an intellectual property portfolio of a dozen essential patents and know-how on related nanotechnology; a consortium of top US and EU scientists\/clinicians including access to clinical trial facilities; government grants from an EU country; and executives with US Food and Drug Administration and European regulatory experience. Its approach is highly capital efficient and applies the concept of open innovation. Presented by: C. Willem Houck, MBA CEO, i-Value UAB and Managing Director, i-Value LLCFrom:FasterCuresViews:3 0ratingsTime:26:35More inNonprofits Activism
<\/p>\n
See the original post here: Presentation- iValue: The Biological Pacemaker 3929 Columbia University is developing a biological pacemaker for human use, offering a cure, rather than the palliation provided by electronic pacemakers, for heart arrhythmia. It uses encapsulated stem cells transfected with the pacemaking gene, which is a path-breaking approach to the treatment of disease. The presenting organization has assembled an intellectual property portfolio of a dozen essential patents and know-how on related nanotechnology; a consortium of top US and EU scientists\/clinicians including access to clinical trial facilities; government grants from an EU country; and executives with US Food and Drug Administration and European regulatory experience. Continue reading
\nPresentation- iValue: The Biological Pacemaker 3929 - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"